- Home
- / Recipharm Leganés
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Recipharm Leganés financials data including stock price, CreditSafe score, income statement, and balance sheet.
Revenue
€55.1 M
FY, 2020
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| EUR | FY, 2018 | FY, 2019 | FY, 2020 |
|---|---|---|---|
| Revenue | 38.1M | 51.2M | 55.1M |
| Cost of goods sold | 8.5M | 10.0M | 11.3K |
| Gross profit | 29.6M | 41.2M | 55.1M |
| Gross profit margin, % | 77.7% | 80.5% | 100.0% |
| General and administrative expense | 13.6M | 13.9M | 15.5M |
| Operating expense total | 20.5M | 22.2M | 24.9M |
| Depreciation and amortization | 47.0K | 382.0K | 755.0K |
| EBIT | 11.7M | 19.1M | 20.1M |
| EBIT margin, % | 30.8% | 37.3% | 36.5% |
| Interest income | 5.0K | ||
| Interest expense | 341.0K | 370.0K | 210.0K |
| Pre tax profit | 11.3M | 18.7M | 19.8M |
| Income tax expense | 2.8M | 4.7M | 5.0M |
| Net Income | 8.5M | 14.0M | 14.9M |